MedTrace Logo

Feasibility of a Behavioural Activation Protocol to Support People With Parkinson's Enhanced by VR

NCT07038603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2025-06-26

No results posted yet for this study

Summary

The proposed research project will involve developing and testing the feasibility of a 6 week Behavioural Activation (BA) programme for people with Parkinson's Disease, which will be enhanced by Virtual Reality exercise programme. The aim of the programme will be to support the mental well-being and physical rehabilitation of people with Parkinson's Disease who are known to Marie Curie Outpatient Department (Belfast).

The main question\[s\] it aims to answer are:

Is a Behavioural Activation (BA) enhanced by a Virtual Reality exercise programme feasible and can it support the mental well-being and physical rehabilitation of People with Parkinson's Disease ?

Can the potential impacts of the intervention help to reduce anxiety and depression, as well as improve balance, social interaction and adherence to the programme?

Participants will:

* Attend a group for 6 weeks with the addition of an introductory session, for 1.5 hours per session.
* During sessions they will be asked to take part in a Behavioural Activation talking therapy. The aim of the intervention is to engage patients through activation strategies and help support adherence to exercise programmes. Participants will complete 'homework' tasks between sessions.
* In addition to this, the BA intervention will be enhanced by Virtual Reality exercises and participants will complete exercises within the immersive space using a VR headset.
* Data collection will capture any changes in depression, anxiety, balance,social interaction and adherence to the programme.
* The intervention will be carried out in three phases.

Conditions

  • Parkinson Disease

Interventions

OTHER

BAPP-VR

A carefully considered adaptation of a BA protocol enhanced with the use of VR

Sponsors & Collaborators

  • Marie Curie Hospice, Belfast

    collaborator OTHER

  • Parkinson's UK

    collaborator OTHER

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Paul Best, Reader · Queen's University, Belfast

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-05
Primary Completion
2023-12-20
Completion
2024-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07038603 on ClinicalTrials.gov